(A) FACS dot plot showing
annexin V binding on myeloid precursors derived from control (control 12 and
control 13), ELANE-mutant SCN iPSCs (SCN15 and SCN14).
(B) Quantitation of the % annexin V binding.
(C) Relative expression of BCL2 in
promyelocytes derived from control and SCN iPSCs. (D) Ectopic
expression of murine Bcl2 through retroviral transduction of myeloid
precursors derived from SCN iPSCs (SCN15). (E) Ectopic
expression of ca-Akt through retroviral transduction of myeloid precursors
derived from SCN iPSCs (SCN15). (F) Quantitation of annexin V
binding in control-, ca-Akt–, or Bcl2-expressing granulocytic precursors
derived from SCN iPSCs. For B and F, data are
presented as mean ± SD of 3 independent experiments. For
C–E, data are presented as mean ± SD of 2 or
more independent experiments in duplicate. Cont,
control.